Reducing medicine-induced deterioration and adverse reactions (ReMInDAR) trial: study protocol for a randomised controlled trial in residential aged-care facilities assessing frailty as the primary outcome.
Renly LimLuke BereznickiMegan CorlisLisa M Kalisch EllettAi Choo KangTracy MerlinGaynor ParfittNicole L PrattDebra RowettStacey TorodeJoseph WhitehouseAndre Q AndradeRebecca BiltonJustin CousinsLan KellyCamille SchubertMackenzie WilliamsElizabeth Ellen RougheadPublished in: BMJ open (2020)
Australian and New Zealand Trials Registry ACTRN12618000766213.